GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (CHIX:GUBRAc) » Definitions » Liabilities-to-Assets

Gubra AS (CHIX:GUBRAC) Liabilities-to-Assets : 0.23 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Gubra AS's Total Liabilities for the quarter that ended in Dec. 2023 was kr145.6 Mil. Gubra AS's Total Assets for the quarter that ended in Dec. 2023 was kr625.3 Mil. Therefore, Gubra AS's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2023 was 0.23.


Gubra AS Liabilities-to-Assets Historical Data

The historical data trend for Gubra AS's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Liabilities-to-Assets Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Liabilities-to-Assets
0.63 0.59 0.50 0.59 0.23

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Liabilities-to-Assets Get a 7-Day Free Trial 0.50 - 0.59 0.19 0.23

Competitive Comparison of Gubra AS's Liabilities-to-Assets

For the Biotechnology subindustry, Gubra AS's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gubra AS's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gubra AS's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Gubra AS's Liabilities-to-Assets falls into.



Gubra AS Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Gubra AS's Liabilities-to-Assets Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Liabilities-to-Assets (A: Dec. 2023 )=Total Liabilities/Total Assets
=145.62/625.28
=0.23

Gubra AS's Liabilities-to-Assets Ratio for the quarter that ended in Dec. 2023 is calculated as

Liabilities-to-Assets (Q: Dec. 2023 )=Total Liabilities/Total Assets
=145.62/625.28
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gubra AS  (CHIX:GUBRAc) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Gubra AS Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Gubra AS's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS (CHIX:GUBRAC) Business Description

Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (CHIX:GUBRAC) Headlines

No Headlines